InvestorsHub Logo

Globewriter

03/26/20 9:31 PM

#333399 RE: eb0783 #333398

Mark Bamforth should agree, though we are finding out he was more concerned with Arranta, Continuus, TriPharm, among others as Bamforth sided with Thermofisher

Chair of board Joseph Carleone understands APIs will be prioritized made in USA and how many kg can Avid produce daily ? 500 Kg of API and expansion paid for with signing of bill tomorrow, marahil. Mo vint toch